In a paper published in Nature, a cancer-like mutation was linked to cerebral cavernous malformations (CCMs), a condition in which blood vessels in the brain are formed abnormally. Currently, the condition can only be treated by means of surgery however the discovery of the mutation has the potential to develop novel therapeutic strategies.
Technology Networks spoke to Douglas Marchuk, PhD and Daniel Snellings of Duke University School of Medicine to find out more about the current state and future prospects of CCM treatment.